Bio-Reference Labs, Inc. (BRLI) Tops Q3 EPS by 2c

August 25, 2011 9:05 AM EDT Send to a Friend
Bio-Reference Labs, Inc. (NASDAQ: BRLI) reported Q3 EPS of $0.36, $0.02 better than the analyst estimate of $0.34. Revenue for the quarter came in at $148.03 million versus the consensus estimate of $146.3 million.


Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here



You May Also Be Interested In


Related Categories

Earnings

Add Your Comment